Lupin Pharmaceuticals Recalls All Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets


Pharmaceutical Recall Related Images

sandimmune box
delsam pharma artificial eye ointment
Buzzagogo Allergy Bee Gone for Kids Nasal Swab
Irbesartan Tablets
Irbesartan Tablets

Lupin Pharmaceuticals Inc. is voluntarily recalling the below-mentioned batches of Irbesartan Tablets and Irbesartan and Hydrochlorothiazide Tablets to the consumer level. As part of Lupin’s ongoing assessment, analysis revealed that certain tested API batches (but not finished product batches) were above the specification limit for the impurity, N-nitrosoirbesartan. Although Lupin has received no reports of illness that appear to relate to this issue, the company, out of an abundance of caution, is recalling all batches of Irbesartan Tablets USP 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg in the US.

Lupin discontinued the marketing of Irbesartan and Irbesartan and HCTZ tabs in Jan 2021.

Risk Statement: N-nitrosoirbesartan impurity is a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests.

From October 8, 2018 (the earliest date of shipment from the manufacturing site of any of the affected batches), to September 30, 2021, Lupin received 4 reports of illness from Irbesartan and 0 reports from Irbesartan and Hydrochlorothiazide.

Irbesartan tablet USP is an angiotensin II receptor blocker indicated for treatment of hypertension, to lower blood pressure, diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. Irbesartan Tablets USP 75mg, 150mg and 300mg is packaged in 30 and 90 count bottles and was distributed nationwide in the US to wholesalers, drug chains, mail order pharmacies and supermarkets. Lupin discontinued the marketing of Irbesartan Tablets on Jan 7, 2021. The recalled lots are included in the table below:

ProductLot NoNDCDistribution Dates
Irbesartan Tablets USP, 75mg H000843, H805727, H901579 68180-410-06 (30’s10/20/2018

12/03/2020 
H000844, H000964, H804311,
H805267, H805268, H805269,
H805725, H805726, H901497,
H901577, H901578, H902258 
68180-410-09 (90’s
Irbesartan Tablets USP, 150mg H804403, H805251, H805640,
H901580 
68180-411-06 (30’s
H804492, H805252, H805253,
H805641, H805642, H805643,
H901581, H902139, H902140 
68180-411-09 (90’s
Irbesartan Tablets USP, 300mg H804310, H900050, H902262 68180-412-06 (30’s
H000845, H000846, H000965,
H805345, H805346, H805347,
H805724, H900061, H900062,
H900445, H901489, H901490,
H901491, H902261 
68180-412-09 (90’s

Irbesartan and hydrochlorothiazide tablet USP is a combination of irbesartan, an angiotensin II receptor antagonist, and hydrochlorothiazide, a thiazide diuretic, indicated for hypertension in patients not adequately controlled with monotherapy or as an initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. Irbesartan and hydrochlorothiazide tablet USP, 150mg/12.5mg and 300mg/12.5mg is packaged in 30 and 90 count bottles and was distributed nationwide in the US to wholesalers, drug chains, mail order pharmacies and supermarkets. Lupin discontinued the marketing of Irbesartan and HCTZ Tablets on Jan 7, 2021. The recalled lots are included in the table below:

ProductLot NoNDCDistribution Dates
Irbesartan and
Hydrochlorothiazide Tablets USP,
150mg/12.5mg 
H804537, H805148,
H900063, H900522,
H901582 
68180-413-06 (30’s10/17/2018

11/18/2020 
H000963, H804507,
H804536, H805070,
H805149, H900064,
H900523, H901583,
H902530 
68180-413-09 (90’s
Irbesartan and
Hydrochlorothiazide Tablets USP,
300mg/12.5mg 
H804192, H805348,
H900065, H902264 
68180-414-06 (30’s
H804082, H804121,
H804338, H804538,
H804539, H805349,
H805350, H900066,
H900067, H902265,
H902275, H902276,
H902531, H902532 
68180-414-09 (90’s

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chains, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product lots.

Patients taking, Irbesartan Tablets USP, 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment.

Wholesalers, distributors and retailers that have Irbesartan Tablets USP, 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg that are being recalled should discontinue distribution of the recalled product lots immediately and return it to Inmar Rx Solutions, Inc., 635 Vine St, Winston Salem, NC 27101. Tel: (855) 769-3988 / (855) 769-3989.

Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (855) 769-3988 / (855) 769-3989 Monday – Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled lots returned to Inmar Rx Solutions, Inc.; the lot number can be found on the side of the bottle label.

Images of recalled product available at FDA.gov

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

  • Complete and submit the report Online
  • Regular Mail or Fax: Download form or call 1- 800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Original recall and updates at FDA.gov


Related Posts

aurobindo pharma usa acetaminophen aspirin and caffeine tablets label
Aurobindo Pharma USA, Inc. Recalls AuroHealth Healthy Living Over the Counter Migraine Relief Acetaminophen/Caffeine Tablets
Aurobindo Pharma USA, Inc. Recalls AuroHealth Healthy Living Over the Counter Migraine Relief Acetaminophen/Caffeine Tablets
clonazepam orally disintegrating tablets
Endo USA, Inc. Recalls Lot 550147301 of Clonazepam Orally Disintegrating Tablets
Endo USA, Inc. Recalls Lot 550147301 of Clonazepam Orally Disintegrating Tablets
volara system
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
Baxter Issues Urgent Medical Device Recall for Volar System Single-Patient Use Circuit
umary acido hialuronica
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules
SoloVital Recalls Umary Acido Hialuronica, Suplemento Alimenticio 850 mg Capsules

Latest Posts

aldi logo
ALDI Recalls Jalapenos, Green Peppers and Green Beans Due to Potential Listeria Contamination
snowfruit logo
JFE Franchising, Inc. Recalls Variety of Products Because Of Possible Listeria
wiers farm cucumber bags and labels
Wiers Farm, Inc Expands Recall on Whole and Salad Cucumbers Due to Possible Listeria
hover 1 dynamo e scooter
DGL Group Recalls Hover-1 Dynamo E-Scooters Sold Exclusively at Walmart
artic cat mountain 600 snowmobile
Textron Specialized Vehicles Recalls 2024 Arctic Cat Mountain 600 Snowmobiles

Leave a Reply

Your email address will not be published. Required fields are marked *

You Are Leaving Us

This link is being provided as a convenience and for informational purposes only it is not an endorsement or an approval of any of the products, services or opinions of the corporation or organization or individual.

Recallinsider.com bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links.